D. E. Shaw & Co., Inc. - BIOMARIN PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$60,998,000
-6.6%
60,985,000
+23.2%
0.06%
-20.5%
Q2 2020$65,316,00049,485,0000.08%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders